Cantor Fitzgerald Starts Immunogen Inc. (IMGN) at Hold, $15 Target
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on Immunogen Inc. (NASDAQ: IMGN) with a Hold rating and a $15 price target Wednesday afternoon.
The firm said the company "is approaching commercial revenue via a partnership with Roche, and this is a solid positive for the stock. However, much of the good news is in the valuation and another catalyst is needed for greater appreciation..."
For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.
The firm said the company "is approaching commercial revenue via a partnership with Roche, and this is a solid positive for the stock. However, much of the good news is in the valuation and another catalyst is needed for greater appreciation..."
For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- SoundThinking (SSTI) PT Lowered to $8 at Cantor Fitzgerald
- Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
